Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Leukemia

Free Subscription Articles published in Biochem Pharmacol Retrieve available abstracts of 20 articles: HTML format Text format

Single Articles

December 2011
1. TONG XZ , Wang F, Liang S, Zhang X, et al
   Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells.
   Biochem Pharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
2. PARK B , Sung B, Yadav VR, Chaturvedi MM, et al
   Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway.
   Biochem Pharmacol. 2011;82:1134-44.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
3. YOSHIDA K , Nagai T, Ohmine K, Uesawa M, et al
   Vincristine potentiates the anti-proliferative effect of an aurora kinase inhibitor, VE-465, in myeloid leukemia cells.
   Biochem Pharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. VANDE VOORDE J , Liekens S, McGuigan C, Murziani PG, et al
   The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2'-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes.
   Biochem Pharmacol. 2011;82:441-52.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
5. CALVINO E , Estan MC, Simon GP, Sancho P, et al
   Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
   Biochem Pharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. ZHANG W , Tan S, Paintsil E, Dutschman GE, et al
   Analysis of deoxyribonucleotide pools in human cancer cell lines using a liquid chromatography coupled with tandem mass spectrometry technique.
   Biochem Pharmacol. 2011;82:411-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
7. LAINEY E , Thepot S, Bouteloup C, Sebert M, et al
   Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: Delineation of anti-leukemic mechanisms of action.
   Biochem Pharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2011
8. KARIUS T , Schnekenburger M, Gelfi J, Walter J, et al
   Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.
   Biochem Pharmacol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2011
9. VALDEZ BC , Li Y, Murray D, Champlin RE, et al
   The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling.
   Biochem Pharmacol. 2011;81:222-32.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. TSUMURAYA T , Ishikawa C, Machijima Y, Nakachi S, et al
    Effects of hippuristanol; an inhibitor of eIF4A; on adult T-cell leukemia.
    Biochem Pharmacol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. DAMARAJU VL , Smith KM, Mowles D, Nowak I, et al
    Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1.
    Biochem Pharmacol. 2011;81:82-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
12. BASTIN-COYETTE L , Cardoen S, Smal C, de Viron E, et al
    Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines.
    Biochem Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. RAKSHIT S , Mandal L, Pal BC, Bagchi J, et al
    Involvement of ROS in chlorogenic acid-induced apoptosis of Bcr-Abl+ CML cells.
    Biochem Pharmacol. 2010;80:1662-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. NATH N , Chattopadhyay M, Pospishil L, Cieciura LZ, et al
    JS-K, a nitric oxide-releasing prodrug, modulates ss-catenin/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism.
    Biochem Pharmacol. 2010;80:1641-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
15. SCHNEKENBURGER M , Grandjenette C, Ghelfi J, Karius T, et al
    Sustained exposure to the DNA demethylating agent; 2'-deoxy-5-azacytidine; leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation; senescence; and autophagy.
    Biochem Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
16. JUNCKER T , Cerella C, Teiten MH, Morceau F, et al
    UNBS1450; a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells.
    Biochem Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. SAIKO P , Graser G, Giessrigl B, Lackner A, et al
    A novel N-Hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).
    Biochem Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. NAIR RR , Tolentino J, Hazlehurst LA
    The bone marrow microenvironment as a sanctuary for minimal residual disease in CML.
    Biochem Pharmacol. 2010;80:602-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
19. ERIKSSON A , Hoglund M, Lindhagen E, Aleskog A, et al
    Identification Of Akn-032, A Novel 2-Aminopyrazine Tyrosine Kinase Inhibitor, With Significant Preclinical Activity In Acute Myeloid Leukemia.
    Biochem Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. CHEN LS , Balakrishnan K, Gandhi V
    Inflammation and Survival Pathways: Chronic Lymphocytic Leukemia as a Model System.
    Biochem Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: